BMS National Menopause Survey – 50% reported their menopause symptoms impacted their sex life.
Categories: hypoactive sexual desire dysfunction HSDD, low libido in women, testosterone for women, menopause, early menopause
Posted: October 30, 2022
The BMS / WHC provides a confidential, independent service to advise, inform and reassure women about their gynaecological, sexual and post reproductive health.
WHC factsheets and other helpful resources
Latest News
World Menopause and Work Day
September 7 is the World Menopause and Work Day. EMAS launched the day in 2021 following the publication of its Global consensus recommendations on menopause… Continue Reading →
The Female Sexual Response—It’s Not Just About Spontaneous Desire
The Female Sexual Response—It’s Not Just About Spontaneous Desire Sexual desire in women often follows a different path than we expect. According to the Basson… Continue Reading →
In Australia, is Addyi (Flibanserin) available or what is available?
Australia Leads the Way in Androgen Treatment for Women with HSDD While the US-approved drug flibanserin offers limited benefit for Hypoactive Sexual Desire Disorder (HSDD), it’s… Continue Reading →